Enavogliflozin
Enavogliflozin (DWP-16001) is a small molecule, orally administered inhibitor of the sodium-glucose cotransporter 2 (SGLT2) . It is utilized in research to investigate SGLT2 function in metabolic diseases, with applications in both in vitro binding assays and in vivo models of diabetes.
Product Specifications
CAS Number
1415472-28-4
Product Name Alternative
Antidiabetic, agent, cotransporter, DWP 16001, DWP16001, DWP-16001, inhibit, orally, Enavogliflozin, Inhibitor, SGLT2, SGLT, selective, Sodium-dependent glucose cotransporters, sodium-glucose
Field of Research
Pharmacology & Drug Discovery
Purity
97.37% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (8.95 mM) ; DMSO:100 mg/mL (223.75 mM)
Smiles
OC[C@H]1O[C@H] ([C@H] (O) [C@@H] (O) [C@@H]1O) c1cc (Cc2ccc (cc2) C2CC2) c (Cl) c2OCCc12
Molecular Formula
C24H27ClO6
Molecular Weight
446.92
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TA500835AM 100 µL
ATP5F1B Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI9E3]
Sign In for Pricing
View Details 